ORION PHARMA (SG) PTE. LTD.

Last Updated: 13 Apr 2026

Orion Corporation is a globally operating Finnish pharmaceutical company – a builder of well-being for over a hundred years. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others. Orion's net sales in 2023 amounted to EUR 1,190 million and the company had about 3,600 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki. Product related questions and feedback: www.orion.fi/en/contact-us/product-related-questions-and-feedback

Country of registration	Singapore
Registration number	202001987N
Local SIC	46461: Wholesale of medicinal and pharmaceutical products (Western)
Incorporation date	15 Jan 2020
Company age	6 years 4 months
Official entity type	Private Limited Company
No. of officers	15

Contact

Address:

5 SHENTON WAY, #12-01, UIC BUILDING, Singapore 068808

Access Key Decision Makers

This is the legal entity page of ORION PHARMA (SG) PTE. LTD.. To access company info, company size, news , key makers’ emails, visit the profile pages above.

The largest company and people database for SEA & ANZ

Associated business (1)

ORION CORPORATION
Finland
View More
Pharmaceuticals
Manufacturing
Orion Corporation is a globally operating Finnish pharmaceutical company – a builder of well-being for over a hundred years. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others. Orion's net sales in 2023 amounted to EUR 1,190 million and the company had about 3,600 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki. Product related questions and feedback: www.orion.fi/en/contact-us/product-related-questions-and-feedback

This is the legal entity page of ORION PHARMA (SG) PTE. LTD.. To access company info, company size, news, key maker's emails, visit the profile pages above.

Financials

Fiscal/Budgeting Period	October - December
Auditor	KPMG LLP
Revenue	1m - 5m
Financial period end date	31 Dec 2021
Share Capital - Ordinary shares	SGD 250,000

Last updated: 13 Apr 2026

* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.

Discover More Companies

Lookalike companies

* This profile contains information from ACRA Information on Corporate Entities from Accounting and Corporate Regulatory Authority which is made available under the terms of the Singapore Open Data Licence version 1.0. Information and datasets on our website are provided on an “as is” and “as available” basis. This website makes no representations or warranties concerning the datasets, including but not limited to any representation or warranty as to the accuracy, completeness, reliability, continued availability, timeliness, non-infringement, title, quality, or fitness for any particular purpose of the datasets to the fullest extent permitted by the law.

Frequently Asked Questions (FAQ)

What is the address of ORION PHARMA (SG) PTE. LTD.?
Where is ORION PHARMA (SG) PTE. LTD.'s headquarter?
What is ORION PHARMA (SG) PTE. LTD.'s contact number?
What ORION PHARMA (SG) PTE. LTD.'s spending power?
Does ORION PHARMA (SG) PTE. LTD. have a presence in the domain it operates in?